GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,553.00p
   
  • Change Today:
      29.50p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,345.40p
  • Currency: UK Pounds
  • Shares Issued: 4,145.04m
  • Volume: 5,189,575
  • Market Cap: £64,372m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
26.85% above the market average26.85% above the market average26.85% above the market average26.85% above the market average26.85% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
1yr Revenue Growth
15.18% below the market average15.18% below the market average15.18% below the market average15.18% below the market average15.18% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth
57.89% below the market average57.89% below the market average57.89% below the market average57.89% below the market average57.89% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio Not Available

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average55.04% below the market average
19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average
Price Chg 3m
54.07% below the market average54.07% below the market average54.07% below the market average54.07% below the market average54.07% below the market average
34.62% below the sector average34.62% below the sector average34.62% below the sector average34.62% below the sector average34.62% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS Not Available
Forecast EPS
81.87% above the market average81.87% above the market average81.87% above the market average81.87% above the market average81.87% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss Not Available

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets Not Available
Cash Not Available

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
86.54% above the market average86.54% above the market average86.54% above the market average86.54% above the market average86.54% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
99.14% above the market average99.14% above the market average99.14% above the market average99.14% above the market average99.14% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
56.77% below the market average56.77% below the market average56.77% below the market average56.77% below the market average56.77% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average
Brokers Percent Neutral
34.08% above the market average34.08% above the market average34.08% above the market average34.08% above the market average34.08% above the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,553.00p
Change Today 29.50p
% Change 1.94 %
52 Week High 1,812.50p
52 Week Low 1,345.40p
Volume 5,189,575
Shares Issued 4,145.04m
Market Cap £64,372m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average40.28% below the market average
80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average80.39% above the sector average
Price Trend
8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average8.93% above the market average
57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average
Income
37.68% above the market average37.68% above the market average37.68% above the market average37.68% above the market average37.68% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
12.69% below the market average12.69% below the market average12.69% below the market average12.69% below the market average12.69% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 26-Jul-2024

Time Volume / Share Price
18:55 100,321 @ 1,669.26p
16:49 8 @ 1,553.00p
16:39 2,580 @ 1,553.00p
16:39 5,160 @ 1,553.00p
16:39 7,740 @ 1,553.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page